$242 Million is the total value of Kopp Family Office, LLC's 13 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 8.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Sell | NeoGenomics Inc. | $91,395,000 | -14.0% | 2,023,355 | -8.2% | 37.83% | -19.9% |
| HZNP | Horizon Therapeutics Public Limited Company | $51,200,000 | +1.7% | 546,775 | 0.0% | 21.19% | -5.2% | |
| VCEL | Sell | Vericel Corporation | $28,322,000 | -11.2% | 539,475 | -6.0% | 11.72% | -17.3% |
| IEFA | Buy | ISHARES TRcore msci eafe | $25,462,000 | +94.0% | 340,128 | +86.8% | 10.54% | +80.7% |
| IEMG | Buy | ISHARES TRcore msci emkt | $18,206,000 | +43.8% | 271,766 | +38.1% | 7.54% | +33.9% |
| FIVN | Buy | Five9, Inc. | $16,785,000 | +61.4% | 91,527 | +37.6% | 6.95% | +50.3% |
| JAMF | New | JAMF HOLDING CORP | $9,851,000 | – | 293,460 | +100.0% | 4.08% | – |
| IVV | ISHARES TRcore s&p500 etf | $126,000 | +8.6% | 292 | 0.0% | 0.05% | 0.0% | |
| ISTB | ISHARES TRcore 1 5 yr usd | $105,000 | 0.0% | 2,050 | 0.0% | 0.04% | -8.5% | |
| IAGG | ISHARES TRcore intl aggr | $43,000 | 0.0% | 783 | 0.0% | 0.02% | -5.3% | |
| IJH | ISHARES TRcore s&p mcp etf | $40,000 | +5.3% | 147 | 0.0% | 0.02% | 0.0% | |
| IMTB | ISHARES TRcr 5 10 yr etf | $39,000 | 0.0% | 764 | 0.0% | 0.02% | -5.9% | |
| IJR | ISHARES TRcore s&p scp etf | $23,000 | +4.5% | 207 | 0.0% | 0.01% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.